Pioneering research in Microdosing GLP-1 The AgelessRx Applied Science Team is leading the first clinical trial focused on the healthspan-enhancing potential of Microdosing GLP-1 Ongoing observational study including long-term tracking of diverse health outcomes in over 1,000 patients using a growing real-world database of patient-reported data Clinical collaborations are currently in development to expand the scope and impact of this research How it works GLP-1s bind to GLP-1 receptors beyond the brain and gut, reaching the heart, kidneys, blood vessels, and immune cells Shown to support signaling to longevity-related pathways like AMPK and mTOR, affecting key Hallmarks of Aging like oxidative stress, inflammation, DNA repair, mitochondrial function, and autophagy At low doses, may subtly restore balance to hormone signaling, reduce inflammation (immune cells), improve cognitive function, and cardiometabolic health Effects may vary based on individual biology and with factors including inflammation, weight, lifestyle, metabolic health, and health history
Therapeutic potential of superoxide dismutase mimetics as therapeutic agents in critical care medicine
But seeing photos of prior patients in before and after photos, it becomes just a bit easier to understand what removing a certain amount of fatty tissue might actually look like
Balcony seats go on sale Tuesday, February 25th at 10am
M., Da Prada, M., Chan-Palay, V., Huber, G., Loffler, J., & Richards, J
